Tularemia. A pathogen in nature and a biological weapon
- PMID: 12227212
Tularemia. A pathogen in nature and a biological weapon
Abstract
Tularemia as a potential biological weapon is of great concern because F. tularensis is a hardy organism that can be spread with a small inoculum. In addition, tularemia can be contracted through nature, predominately in rural areas. This disease can be spread by a wide variety of animals and can range from skin lesions to multi-organ involvement. The severity varies with amount of inocula, the virulence of the bacterium, and the port of entry. Exposure to aerosolized forms of F. tularensis, the major concern with bioterroism, can rapidly lead to respiratory failure and death. Untreated, other forms of tularemia can spread through the blood stream to other organs, leading to sepsis and death. Early recognition and treatment is tantamount to treatment and prevention of morbidity and mortality. Occupational health nurses are on the front line and must be assertive in identifying risk factors associated with exposure. Furthermore, education of the general population about exposure through nature can potentially decrease the incidence of tularemia. Occupational health nurses, as one of the largest health specialties in the workplace, may be the first contact for the exposed individual. Tularemia is treatable with knowledge of prevention, astute assessment, prompt identification, and treatment. Combined, they are powerful nursing tools in achieving optimal outcomes.
Similar articles
-
Bioterrorism's invisible threats: heightened awareness will help nurses identify real and suspected bioterrorism.Nurs Manage. 2002 Jan;33(1):43, 45-7. Nurs Manage. 2002. PMID: 11984331
-
Tularemia.Semin Respir Infect. 2003 Sep;18(3):146-58. Semin Respir Infect. 2003. PMID: 14505277
-
Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia.Euro Surveill. 2004 Dec 15;9(12):E9-10. Euro Surveill. 2004. PMID: 15677845
-
Bioterrorism: class A agents and their potential presentations in immunocompromised patients.Clin J Oncol Nurs. 2008 Apr;12(2):295-302. doi: 10.1188/08.CJON.295-302. Clin J Oncol Nurs. 2008. PMID: 18390465 Review.
-
[Tularemia as a biological weapon].Harefuah. 2002 May;141 Spec No:78-83, 120. Harefuah. 2002. PMID: 12170560 Review. Hebrew.
Cited by
-
Route of Francisella tularensis infection informs spatiotemporal metabolic reprogramming and inflammation in mice.PLoS One. 2023 Oct 26;18(10):e0293450. doi: 10.1371/journal.pone.0293450. eCollection 2023. PLoS One. 2023. PMID: 37883420 Free PMC article.
-
Chronically hypertensive transgenic mice expressing human AT1R haplotype-I exhibit increased susceptibility to Francisella tularensis.Front Microbiol. 2023 May 17;14:1173577. doi: 10.3389/fmicb.2023.1173577. eCollection 2023. Front Microbiol. 2023. PMID: 37266014 Free PMC article.
-
Nlrp3 Increases the Host's Susceptibility to Tularemia.Front Microbiol. 2021 Oct 6;12:725572. doi: 10.3389/fmicb.2021.725572. eCollection 2021. Front Microbiol. 2021. PMID: 34690967 Free PMC article.
-
Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.PLoS One. 2018 Apr 23;13(4):e0194614. doi: 10.1371/journal.pone.0194614. eCollection 2018. PLoS One. 2018. PMID: 29684046 Free PMC article.
-
Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.PLoS One. 2015 Jun 22;10(6):e0130858. doi: 10.1371/journal.pone.0130858. eCollection 2015. PLoS One. 2015. PMID: 26098553 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical